7.08 USD
↗ 0.24 (3.43%)AT CLOSE (11:59 AM EDT)
Seres Therapeutics, Inc.
MCRBNASDAQ • USD
7.04
↘ 0.04 (0.57%)
POST MARKET (AS OF 05:05 PM EDT)
Post Market
AS OF 05:05 PM EDT
7.04
↘ 0.04 (0.57%)
Market: CLOSED
Seres Therapeutics, Inc. (MCRB) trades at $7.08 per share. MCRB shows a split signal: technical indicators suggest "Buy" while underlying fundamentals indicate "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. Valuation metrics place MCRB at a fair price relative to peers.
Technical & fundamental data as of Jun 26, 2026.
Open?$6.85
High?$7.57
Low?$6.85
Prev. Close?$6.85
Volume?301.5K
Avg. Volume?80.9K
VWAP?$7.08
Rel. Volume?3.73x
Bid / Ask
Bid?$5.72 × 100
Ask?$8.68 × 100
Spread?$2.96
Midpoint?$7.20
Valuation & Ratios
Market Cap?68.6M
Shares Out?9.7M
Float?6.9M
Float %?70.8%
P/E Ratio?N/A
P/B Ratio?2.59
EPS?-$4.84
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates. Its pipeline includes candidates such as SER-155 and SER-603, aimed at preventing and treating bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases. The company operates as a single reportable segment, mainly developing microbiome-based therapies targeting bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases.
Employees
66
Market Cap
66.3M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2015-06-26
Address
200 SIDNEY STREET
CAMBRIDGE, MA 02139
Phone: 617 945 9626
CAMBRIDGE, MA 02139
Phone: 617 945 9626
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?18
Short Sent.?65
Piotroski F-Score?0/9Weak
Altman Z-Score?-13.68Distress
Confidence?45%Low
Short InterestLow
Short % of Float?3.20%Low
Short Interest?219.8K
Days to Cover?2.2
Free Float6.9M
Avg Daily Volume102.1K
Settlement Date2026-06-15
Financial Health
Current Ratio?1.65Adequate
Quick Ratio?1.65Adequate
Cash Ratio?1.54Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?2.59CHEAP▾
Peers100
S&P63
P/S?59.78HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-0.5CHEAP▾
S&P97
EV/Sales?33.76HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-177.0%WEAK▾
S&P3
ROA?-39.9%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-42371000
Enterprise Value?$38.7M
Fundamentals ratios updated end of day